This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Greenovation Biotech Gmbh, Igeneon Krebs-Immuntherapie Forschungs-Und Entwicklungs-Ag, Meridian Biopharmaceuticals Gmbh. Active years: 2010-2011.
Company Filing History:
1 out of 12 
1 out of 3 
1 out of 2 Years Active: 2010-2011
Title: Gunter Waxenecker: Innovator in Monoclonal Antibody Development
Introduction
Gunter Waxenecker is a notable inventor based in Mank, Austria. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Gunter Waxenecker holds a patent for an invention titled "N-glycosylated antibody." This invention relates to a monoclonal antibody, or a fragment of the antibody, derived from a parental monoclonal antibody that recognizes the Lewis Y antigen. The invention is characterized by the Fc region of the antibody, or fragment, carrying a bi-sected hybrid type N-glycosylation pattern. Notably, this antibody demonstrates at least a tenfold increase in antibody-dependent cellular cytotoxicity (ADCC) and at least a 10% reduction in complement-dependent cytotoxicity (CDC) activity. This patent highlights his innovative approach to enhancing the efficacy of therapeutic antibodies.
Career Highlights
Throughout his career, Gunter has worked with several prominent companies in the biotechnology sector. He has been associated with Greenovation Biotech GmbH and Meridian Biopharmaceuticals GmbH, where he has contributed to various research and development projects. His work in these organizations has further solidified his reputation as a leading inventor in the field.
Collaborations
Gunter has collaborated with notable professionals in the industry, including Manfred Schuster and Gottfried Himmler. These collaborations have allowed him to expand his knowledge and expertise, leading to innovative breakthroughs in monoclonal antibody research.
Conclusion
Gunter Waxenecker's contributions to the field of biotechnology, particularly through his patent for N-glycosylated antibodies, demonstrate his commitment to advancing medical science. His collaborations and career highlights reflect his significant impact on the industry.